Portfolio return of -9.5% drove $48.4m loss as NAV per share fell

That drawdown produced a net loss of NZ$48.4m versus a NZ$56.9m profit in HY22 (-185.0%), the weakest result in Annolyse's historical baseline (four-period mean +91.1%, range -61.7% to +391.0%). NTA per share fell from NZ$1.88 to NZ$1.37, and net assets attributable to shareholders declined 25.2% to NZ$444.4m from NZ$594.4m.

The investment-loss line of NZ$45.9m (-172.7% versus prior) reflects fair-value losses on the portfolio of around NZ$50.9m, partly offset by dividend and interest income, which rose to NZ$5.0m from NZ$4.6m (+8.1%). Cash balances fell from NZ$20.7m to NZ$8.9m. The interim dividend component was 2.86 cps versus 3.67 cps, with 5.99 cps paid during the period under the quarterly distribution policy.

A -0.9pp gap to benchmark this half compares with +4.7pp of outperformance in HY22. The benchmark return itself is classified as unprecedented_low in the supplied baseline (four-period range -4.9% to +5.7%), so most of the loss is market-driven; but the company did not add value within that drawdown, which matters because investors pay for active management.

NAV base contracted 25.2%. Net assets attributable fell from NZ$594.4m to NZ$444.4m, the lower edge of the four-period range (mean NZ$497.2m). NTA per share at NZ$1.37 remains within Annolyse's historical normal range, but the absolute asset base now generates fees and supports distributions from a materially smaller pool.

Distribution coverage at 39.5% sits below the historical mean. Underlying dividend and interest income covered 39.5% of distributions paid (lower edge of the four-period range, mean 44.6%). With ROE at -10.9% — unprecedented_low against a historical mean of 4.8% (range -3.4% to 9.6%) — the residual distribution is funded from realised gains and the capital base, not from period earnings.

The HY22 comparable was followed by an FY22 full-year investment loss of NZ$10.7m, implying a sharply weaker second half that consumed earlier gains — Annolyse's shape data records HY22 as 593% of FY22 investment income. That historical shape is not a forecast for HY24 but underlines that intra-year portfolio swings can be large.

The release supports a reading of a market-driven drawdown aligned with a weak benchmark; it does not support any judgement on recovery timing, persistence of underperformance, or distribution sustainability beyond what current coverage implies.

Dividend and interest income of NZ$5.0m grew 8.1% and sits at the lower edge of the historical range (mean NZ$5.4m) — a stable, recurring contribution. Operating cash flow of NZ$13.6m reflects portfolio rebalancing flows rather than recurring economics; the company-reporting-shape guidance is to treat fair-value movements as portfolio return, not operating margin.

The headline loss is essentially fair-value driven: investment losses of approximately NZ$50.9m drove the NZ$45.9m total revenue/loss outcome. The result is therefore reversible with markets but offers no internal cushion. Distribution coverage of 39.5% means roughly 60 cents in each dollar of dividend came from capital or realised gains, and the cash balance fell NZ$11.7m. ROE of -10.9% lies outside the supplied four-period range, which is the cleanest single signal that this is not a marginal miss.

This briefing cannot assess the underlying portfolio holdings, sector concentration, or any post-period market recovery that may have offset the half-year drawdown.